Lee Greenberger, PhD, has retired as The Leukemia & Lymphoma Society’s chief scientific officer after more than a decade in ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

The Oncologist explained how environmental toxins can lead to blood cancer. Know the precautionary tips to take.

Independent Data Monitoring Committee to Perform Interim Analysis of Phase 3 REGAL Study in January 2025 - - SLS009: Full Topline Phase 2 Data in Acute Myeloid Leukemia and FDA Regulatory Review Expec ...

Independent Data Monitoring Committee to Perform Interim Analysis of Phase 3 REGAL Study in January 2025 -- SLS009: Full Topline Phase 2 Data ...

Two posters presented at the 2024 American Society of Hematology meeting reported real-world outcomes data for patients ...

A new study evaluating the quadratic phenotypic optimization platform shows it can accurately predict personalized drug ...

cDepartment of Maternal Fetal Medicine, Royal Hospital for Women, Sydney, NSW, Australia dMotherSafe, Royal Hospital for Women, Sydney, NSW, Australia eDepartment of Obstetric Medicine, Royal Hospital ...

Your bone marrow contains blood stem cells that have the potential to become two other types of stem cells called myeloid and lymphoid stem cells. Myeloid stem cells can become red blood cells ...

Myeloid derived suppressor cells (MDSCs) are bone marrow (BM)-derived cells with potent suppressive properties, implicated in T cell inhibition and tumour dissemination. In Diffuse Large B-cell ...

Venetoclax is under clinical development by AbbVie and currently in Phase II for Refractory Acute Myeloid Leukemia. According to GlobalData, Phase II drugs for Refractory Acute Myeloid Leukemia have a ...